Home | Site Map | Contact Us | Bookmark  
 
  Single Disease Educational Content
  Multi-Disease
Educational Content
  Other Resources
  About CLDF
 

              Drug & Device Development

Back  
     
 
 

01-18-2012

Four-drug therapy wiped out hepatitis C virus in most cases

01-13-2012

Rituximab helpful against HCV cryoglobulinemic vasculitis

01-06-2012

Adjuvant interferon doesn't prevent HCC recurrence

01-03-2012

Aveo kidney cancer drug improves survival in late stage

01-04-2012

Experimental hepatitis C vaccine shows early promise

01-02-2012

Stem cell preconditioning boosts liver volume before resection

12-29-2011

Combination therapy useful for advanced hepatoma

12-27-2011

Severe cryoglobulinemic vasculitis responds to rituximab therapy

12-23-2011

Bristol-Myers liver cancer drug brivanib fails phase III trial

11-11-2011

Pharmasset upbeat on drug for resistant hep C strain: CEO

11-10-2011

Stool color cards hasten referrals for biliary atresia

11-07-2011

Smallpox vaccine extends life in phase II hepatoma trial

09-29-2011

Vertex takes early rounds of hep C bout with Merck

09-07-2011

Adding telaprevir improves chronic hepatitis C therapy

09-06-2011

Pharmasset hep C drug shows promise in mid-stage trial

08-04-2011

Midodrine controls ascites, improves survival in cirrhotic patients

08-03-2011

Radiofrequency ablation a good option in early HCC, for some

07-28-2011

Perflubutane improves intra-op ultrasound diagnosis of HCC

07-26-2011

Vertex says combo hepatitis C treatment works

07-18-2011

Pitavastatin may enhance antivirals in some hepatitis C patients

06-03-2011

Renal effect of tenofovir is milder when it's used only for HBV

05-25-2011

Particle therapy promising in liver cancer

05-19-2011

Exelixis drug cabozantinib shown to control solid tumors

05-06-2011

Faster hepatitis B vaccine schedule has benefits in pregnancy

05-03-2011

Thiazolidinediones minor help in non-alcoholic steatohepatitis

05-02-2011

Advantages of stereotactic body radiation therapy remain questionable

04-28-2011

Selumetinib fails in HCC trial, minimally better in biliary cancer

04-27-2011

Telbivudine during pregnancy safely reduces vertical transmission of HBV

04-20-2011

Stereotactic radiotherapy helpful in colorectal liver metastases

04-12-2011

Vena cava clamping reduces hepatic resection blood loss

04-12-2011

More immunogenic HBV vaccine regimens better in HIV-infected patients

04-08-2011

High-intensity ultrasound gets high marks for HCC ablation

03-25-2011

Early liver biopsy important in alcoholic cirrhosis

03-15-2011

BCAAs won't prevent recurrent hepatic encephalopathy

03-10-2011

Low-dose interferon safe, effective for dialysis patients with hepatitis C

03-03-2011

Antiviral therapy lowers insulin resistance in HCV genotype 1 infection

02-28-2011

Rifaximin improves cognitive function in hepatic encephalopathy

02-24-2011

Adding telaprevir shortens HCV treatment for many

02-17-2011

Bevacizumab combo "encouraging" for advanced hepatoma

02-16-2011

Children with chronic hepatitis C respond well to peginterferon plus ribavirin

02-02-2011

Mycophenolate mofetil helps avoid steroids for autoimmune hepatitis

01-28-2011

Study finds no evidence black cohosh damages liver

01-26-2011

Ambrisentan promising in portopulmonary hypertension

01-26-2011

Peginterferon clears hepatitis D virus in nearly one quarter of cases

01-14-2011

Sanofi confirms liver damage in 2 Multaq patients

01-06-2011

No benefit from adjuvant bevacizumab for colon cancer metastases to liver

 
     
 

2010

2009

2008

2007

2006

2005

2004

 

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2009 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource
for US healthcare providers only. Use of this Web site is governed by the CLD Foundation terms of use and privacy statement./td>